Background: Vaccine coverage amongst adults for recommended vaccines is generally low. In
Introduction
Despite the availability of internationally recommended, safe, and effective vaccines for adults, such as those preventing influenza, pneumococcus, and herpes zoster, adult immunization coverage remains poor [1] [2] [3] [4] . There are various reasons for the poor coverage, including public apathy, lack of education around vaccines and vaccine-preventable diseases, cost, and convenience [5, 6] . One strategy used to improve immunization coverage in adults, is the use of nontraditional immunization providers, such as pharmacists, to improve accessibility and convenience for immunizations [7] [8] [9] . It is estimated that 55% of adults visit a pharmacy in any given week, which provides pharmacists ample opportunity to interact and assess for vaccine needs [10, 11] . A pharmacists' recommendation to be immunized has been shown to have a similar effect on a person's decision to be immunized as that of a physician or nurse [12] .
Pharmacists in the United States began immunizing in 1996 when a national vaccination training program for pharmacists was implemented and since that time increased public awareness, improved access, and higher rates of adult immunization have been seen in states that allowed pharmacists to vaccinate compare to those that did not [13] [14] [15] [16] [17] . In the US, more than 260,000 pharmacists have been trained to administer vaccines across the lifespan; most have been trained in a nationally recognized certificate training program [18] . In 2007, Alberta became the first province in Canada to expand pharmacists' scope of practice to include administration of vaccines and as of March 2015, 8 provinces allowed this expanded scope of practice [19] .
In Canada, pharmacists' primary immunization administration role has been in providing seasonal influenza vaccine and little is known about the attitudes of pharmacists, other health care providers, or the public, regarding the expansion of the role of pharmacists to include a full range of adult immunizations [19] . The purpose of this study was to assess the attitudes of a representative national sample of healthcare providers and the public about pharmacists as immunizers.
Results

Survey
A total of 4023 adults completed the survey; 2252 (56%) were men and 1771 (44%) were women ( Table 1 ). More respondents were 45-54 years of age and fewer were younger than 25 years and 75 years and older. Respondents were representative of the Canadian population by province and by urban/suburban residence. For the HCP survey, there were 1167 respondents comprising 42.8% family physicians, 5.6 % internists, 34.3% pharmacists and 17.3% nurses. Most (83.9%) practiced in an urban/suburban setting. Ninety-three percent of physicians, 41% of pharmacists and 54% of nurses provided direct patient care at least 75% of the time.
Providers in all three professions surveyed strongly agreed that it was important to inform adults about the benefits and risks of adult immunization and to use other health encounters to check on immunization status (Table 2) . A majority (54.5-64.3%) of HCPs from the three professions agreed that it was difficult to keep up with adult vaccine recommendations and 68.1-83.0% agreed that keeping track of immunization status of their adult patients was difficult. One-third of pharmacists agreed that they did not have time to administer vaccines to adults while only 16% of nurses and 25% of physicians agreed with this statement. Concern about insufficient time to administer vaccines was least in British Columbia and the Prairies where pharmacists were already immunizing ( Figure 1A ). Substantial differences were detected in support of expansion of the scope of practice of pharmacists to immunize; pharmacists were most supportive, physicians least supportive, and nurses were intermediate. There was a trend toward more hesitancy to expand pharmacist scope of practice to include children over 5 years of age, particularly amongst physicians. HCPs' willingness to be immunized themselves by a pharmacist and willingness to refer their patients to a pharmacist for immunization closely mirrored the level of support for the expansion of scope of practice. Logistical issues such as sufficient storage facilities to provide adult vaccines did not appear to be a differentiating issue between the health professions.
Pharmacists were less likely than doctors and nurses to have a system in place for identifying adults who needed vaccination. Reimbursement for vaccination was more of an issue for pharmacists than physicians and was not an issue for nurses.
A majority of the Canadian adult public was willing to receive their vaccines and have their children vaccinated by a pharmacist; support was greater for adult compared to childhood vaccination (Table 3 ).Willingness to be immunized in a pharmacy was similar in all regions of the country, regardless of whether pharmacists were already providing vaccination services ( Figure   1B ). While 80.4% of the public reported getting their health-related information from their family doctor or nurse, pharmacists were identified as a source of this information by 44.5% of respondents, a level similar to public health officials (48.5%), the media (50.6%), the internet (52.2%) and family members (45.7%). Importantly, however, pharmacists were identified as a trustworthy source of health information by 75% of respondents, similar to public health officials (68.3%) and exceeded only by family doctors and nurses (89.2%). Media (28.5%), the internet (34.0%), family (43.0%), and friends (29.6%) were identified much less frequently as a source of trusted health information. A physician/nurse recommendation to receive a vaccine was reported to be more influential than a pharmacist recommendation for a number of vaccines routinely recommended for adults.
Only 46.3% of survey respondents reported being up to date on all their adult immunizations and an additional 30% did not know ( Table 1) . The frequency that the public visits a pharmacy compared to a physician's office may provide an opportunity to improve vaccine coverage rates for recommended adult vaccines. Almost 95% of respondents reported visiting a pharmacist compared to 83.9% visiting a physician at least once a year (Table 1) . More strikingly, 55.2% of respondents reported visiting a pharmacist compared to only 8.1% visiting a physician at least once per month. Respondents were reluctant to pay for the convenience of pharmacy delivered vaccines; 46.4% would be willing to pay up to $5 for the pharmacist vaccine administration and only 16.4% would be willing to pay up to $20 (Table 3) . In keeping with the public's comments concerning the management of adverse events, most HCP participants agreed that all pharmacists who administer vaccines must be properly trained to deliver vaccines and work in facilities that can support the ability to manage vaccine adverse events appropriately.
Focus Groups
"I would as long as they got the appropriate training by a credited source" (BC, HCP)
"If they have adequate facilities and they can deal with adverse effects, yes, but I don't think this is what they have now." (ON, HCP)
"Yes, if the person giving the vaccine was properly trained to administer the vaccine and deal with allergic reactions" (AB, Public)
Most HCP stated that it would be much easier for the public to access vaccines at a pharmacy especially for those adults who do not have a family physician or a HCP they visit on a regular basis. The public also agreed with this statement and stated that pharmacy delivered vaccination would lessen the burden on family physicians.
"But I think the more people you can get on board to administer the Tdap vaccine the better…. If the pharmacy starts giving it, when they go to pick up their monthly prescriptions they could have it administered there." (PEI, HCP)
"I would prefer a pharmacist over a public health clinic due to lack of line ups and the ability to make an appointment." (AB, Public)
"Yes if pharmacists can speed up the process, if it's hard to get the vaccine elsewhere or if the hours don't allow you to get it easily."(QB, Public)
Tracking of vaccination status and costs were raised as concerns by the HCPs. Many HCP's felt that duplication of records would occur and that the family physician would not have complete documentation of their patient's vaccination status if their patients received their vaccines at a pharmacy.
"You don't want duplication, go get this vaccine from the GP and this one at the pharmacy, it would be difficult." (ON, HCP).
HCPs also suggested that the cost of the vaccine should be the same or lower when administered in a pharmacy as opposed to a physician's office.
"If it is less cost for the patient, yes I would refer the patient" (BC, HCP)
"If they got it for free I would say go there." (PEI, HCP)
Many pharmacists were quite receptive to the idea of administering adult vaccines to the public, but felt that this practice would be most relevant during times of a crisis such as during a pandemic or flu season.
"I think during a pandemic we can give help because we have to vaccinate a lot of people very quickly." (ON, HCP)
In British Columbia, participants stated that pharmacists who deliver vaccines are able to vaccinate individuals who are unable to visit their family physicians due to time constraints.
"We are catching those who fall through the cracks or those who do not have the time to go to their family physician." (BC, HCP)
The public as well as HCPs stated that pharmacists as well as doctors and other health care workers should act as authority figures or spokespeople for the purpose of promoting the vaccine. 
DISCUSSION
Adult vaccination rates for recommended vaccines, such as influenza, Tdap, pneumococcal and herpes zoster remain sub-optimal [20] [21] [22] . Barriers to achieving high vaccination rates in adults are multifactorial, including lack of education about vaccines and vaccine-preventable diseases, infrastructural issues including access to vaccines and health care providers, financial concerns, and the attitudes of patients and providers toward vaccination [23] . Interventions that enhance access to vaccinations can improve vaccine coverage [24] . The addition of pharmacists as immunization providers is one way to expand access and subsequently improve vaccination coverage [13] [14] [15] [16] [17] .
Early studies in Canada have shown success for the addition of pharmacists as immunizers of influenza vaccine [25, 26] . Many provinces are allowing the administration of additional vaccines by pharmacists; however, the uptake is not well known at this time, as many vaccines are purchased privately and not provided through public health.
The success of implementation of pharmacists as vaccine providers in Canada on overall vaccine uptake can be optimized by understanding and responding to the factors impacting acceptability of pharmacist immunizers by both the Canadian public and conventional providers. The results of our nationwide representative sampling, by survey and focus groups, of health care providers and the public demonstrate moderate support for immunization by pharmacists but also identify some barriers to widespread support among both the public and providers which will need to be addressed. While 82% of pharmacists would support the expansion of pharmacists' scope of practice to include provision of vaccines to adults, a substantial minority of nurses and physicians (32% and 46%, respectively) would not support this change in practice and less than half of nurses and physicians surveyed would refer their patients to a pharmacist for immunization or feel comfortable themselves receiving vaccines from a pharmacist. While most HCP acknowledged that it would be more convenient for patients to access adult vaccines at a pharmacy and that administration of vaccines by pharmacists would reduce the burden on family physicians for this service, HCP respondents indicated that they would feel comfortable referring patients to pharmacists for vaccination only if stringent guidelines for training were in place. Notably, HCP wanted assurance that pharmacists had received training not only to vaccinate but also to safely manage adverse events following immunization, particularly anaphylaxis. Record keeping was also raised as a concern in our study. HCP wanted assurance that pharmacist records of vaccine administration would be available to their other care providers and were concerned that there might be inadequate records or duplication of vaccine delivery if patients receive some vaccines in a pharmacy. Pharmacist respondents in provinces that did not allow pharmacists to immunize had concerns around the logistics of administering vaccines in their pharmacy, specifically a lack of time; however, these concerns were noted to a lesser extent in pharmacist respondents in provinces that allowed pharmacists to immunize adults.
In our study, support for pharmacists as immunizers was higher amongst the public than among HCP. Almost two-thirds of the public surveyed would be willing to receive their vaccinations from a pharmacist and more than half would be willing to have a pharmacist vaccinate their children.
Over half of public respondents agreed or strongly agreed that it would be more convenient to receive vaccines from their pharmacist. Almost half of public respondents report receiving their health information from a pharmacist and 75% consider pharmacists a trusted source of health information. None the less, respondents were slightly more likely to receive vaccines if recommended by their physician or nurse than by their pharmacist. Like HCP, public respondents wanted assurance that pharmacists had received adequate training to administer vaccines and to treat allergic reactions. Our study also revealed cost to be a potential barrier to public acceptance of vaccination by a pharmacist. Less than half of respondents were willing to pay even $5.00 per vaccine administered by a pharmacist and only 16% would pay $20.
Previous studies have shown that the addition of pharmacists as vaccine providers resulted in improved access and higher rates of adult immunization [13] [14] [15] [16] [17] . There is evidence that pharmacists can specifically increase access and immunization rates in rural areas, which are areas that are usually underserviced by physician and/or public health clinics [25, 27, 28] . Other studies have found that patients appreciate pharmacy immunization services, as they offer convenient times and locations, as well as the ability of pharmacists to provide vaccinations during "off-clinic hours", such as evenings, weekends, and holidays, when traditional providers are often not available [29, 30] . One study found that almost one-third of pharmacy immunization recipients received vaccines during "off-clinic hours" [29] . A Canadian pilot study found that pharmacy based clinics were the preferred site for receiving immunization, due to convenience, less waiting time, not having to make an appointment, and easier parking [30] .
In order to fully realize the potential benefits of pharmacists as immunizers, work remains to be done to educate both conventional immunization providers and the public and to ensure adequate pharmacists receive and that this is contributing to hesitance to refer patients to pharmacists or to accept immunization from a pharmacist. This could be readily addressed through educational and marketing initiatives from pharmacists' professional associations and colleges.
Concerns about cost and reimbursement will require systematic change to ensure reimbursement schemes are in place to allow pharmacists to provide vaccines to patients under the same funding model as other providers, such as physicians and public health. If the vaccine is funded by the public health care system, it should be available to patients from all authorized immunization providers and reimbursement schedules should be negotiated to ensure delivery by pharmacists is not impeded by a need to pass administration costs on to patients. In summary, low vaccine coverage in adults remains a concern. The addition of pharmacists as vaccine providers has been shown to improve access and vaccination coverage. We have shown that there is general support from the Canadian public and healthcare providers to expand the scope of pharmacists practice to include immunization but that several key issues must be addressed to ensure optimal impact of pharmacists to improve coverage rates among adults.
While expanding the number of immunizers to include pharmacists is an important step, fundamental changes have been identified that must occur in order to address low vaccine coverage in adults. Among the issues that must be considered in a comprehensive adult vaccination strategy are the changing demographics of an increasingly aging population, addressing the bias that may prioritize vaccination programs for children in favor of adult programs, undertaking research and development into understanding the decreased immune response to immunization with increasing age (immunosenescence) and increasing translational research to develop vaccines that overcome these issues, improving measurement and reporting of vaccine coverage rates in adults, implementing innovative and transformative adult immunization programs, and designing creative education programs [33] . Infrastructure for providing vaccines to adults is inadequate [34] and improving access to vaccinations is an important component for the improvement of vaccine coverage. Given the current degree of support for pharmacists as immunizers in Canada and the excellent training and legislative processes already in place in some jurisdictions, optimizing pharmacist delivery of vaccination to adults as a means to increase accessibility and coverage is a logical next step in the development of a comprehensive adult immunization strategy in Canada.
Methods
We used a mixed method, sequential, explanatory design consisting of quantitative data collection and analysis (survey) followed by qualitative data collection and analysis (focus groups) [35, 36] ; details of the methodology have previously been published and are summarized here [37, 38] Sampling was designed to ensure appropriate representation based on regional population, age, gender, and urban and rural residence. Inclusion criteria were being 18 years of age or older, having internet access and being willing and able to complete the self-administered questionnaire.
A subset of health care providers (HCP) within this database was invited to participate in the HCP survey; sampling was based on regional representation, age, gender, urban and rural practice, and specialty (general practice physicians, internal medicine specialists, nurses, pharmacists).
Inclusion criteria were being in practice for a minimum of 3 years, responsibility for immunization delivery and/or patient consultation concerning vaccines in their province or territory, internet or telephone access, and willingness/ability to complete the interview. Participants received an email invitation to the survey outlining the purpose of the study, its voluntary nature, and the time commitment involved. Consent to participate was implied by completion of the web-based survey.
For the public survey, a sample size of 4000 adults was calculated to provide an acceptable precision by region (95% confidence interval around the point estimate) of ±5%. For the HCP survey, a sample size of 500 family physicians and 400 pharmacists was calculated to provide an acceptable precision (95% confidence interval around the point estimate) of ±5%; a sample size of 100 internal medicine specialists and 200 nurses was calculated to provide an acceptable precision of ±5-10% for each practitioner type. Point estimates with 95% confidence intervals were calculated. The first level of analysis comprised a review of the descriptive, summative statistics for trends in the data. The second level of analysis involved tests of association. Data were divided by public and by HCP's profession (physician, nurse, pharmacist) and locale (province/territory).
In general, continuous variables were presented by summary statistics (i.e., mean and standard error) and the categorical variables by frequency distributions (i.e., frequency counts, percentages and their two-sided 95% exact binomial confidence intervals). Differences in survey responses between groups were assessed using Fisher's exact tests. For continuous variables, logistic regression was used. Associations between attitude questions, behavioral responses and demographics were estimated using ordinal logistic regression or Fisher's exact tests. P-values < 0.05 were considered statistically significant.
Qualitative Stage (Focus Groups)
Focus groups were administered by Leger Marketing in multiple locations across Canada using a semi-structured facilitation guide. For the public, six traditional face-to-face focus groups and two "virtual" focus groups (web-based teleconferences) were undertaken. For HCP, six traditional face-to-face focus groups, two "virtual" web-based focus groups and four one-on-one interviews were undertaken. Regional representation was sought with a balance of rural and urban residence for the public and large and small urban areas, suburban, and rural practices for HCP. Inclusion criteria for the public survey were being an adult aged 21 to 65 with 2/3 of participants per focus group having frequent contact with children. HCPs invited to participate in the focus groups included physicians, nurses and pharmacists. Inclusion criteria for participation were being a HCP who routinely provides immunizations or advice about immunization to their patients and was practicing for a minimum of 3 years. HCP included nurses, pharmacists, and physicians (including general practitioners, internists and emergency room physicians). A maximum quota of two pharmacists and one physician per group was imposed.
All focus groups were recorded and transcribed verbatim. A debriefing by investigators with the moderator team took place immediately following the focus group. Thematic analysis was initiated concurrent with the first focus group as previously described [37, 38] . Transcripts were labeled and categorized by two investigators according to similarities and related patterns as well as for differences, followed by combining and cataloguing similar patterns into sub-themes (NUD*IST software version N9, Sage Publications Ltd, London, UK). 
